Please provide your email address to receive an email when new articles are posted on . In a joint consensus statement issued by the Heart Rhythm Society and the American College of Cardiology ...

This story is part of a series on the current progression in Regenerative Medicine. This piece discusses the regeneration of the cardiovascular system. In 1999, I defined regenerative medicine as the ...

August 1, 2012 (Calgary, Alberta) — A joint consensus statement issued by the Heart Rhythm Society (HRS) and the American College of Cardiology Foundation (ACCF) recommends that patients with ...

Editor’s Note: The following guest post is published with the permission of its author, Edward J. Schloss, MD, (Twitter ID @EJSMD) the medical director of cardiac electrophysiology at Christ Hospital ...

Approximately 50,000 single-chamber pacemakers are currently implanted in the U.S. each year; until now, these patients have not been able to access MRI scans. BIOTRONIK is the first company in the ...

Please provide your email address to receive an email when new articles are posted on . The first pacemaker implantation was performed in 1958, and the technology has undergone many advances since ...

Guidelines that recommend dual-chamber pacing over single-chamber pacing for treatment of atrioventricular block have recently been questioned. Previous clinical trials supporting these ...

The product is Abbott’s Aveir system, which is the world’s first approved dual-chamber pacemaker. Other leadless pacemakers are single chamber, meaning they connect to one chamber in the patient’s ...

More expensive pacemakers that “pace” the heart’s upper and lower chambers are worth the extra cost because they can reduce the risk of hospitalization and disability in patients with heart disease, ...

The FDA approved the Aveir DR dual-chamber leadless pacemaker, the first such device to make it to the market, manufacturer Abbott announced. Approved for the treatment of abnormal or slow heart ...

In the treatment of atrioventricular block, dual-chamber cardiac pacing is thought to confer a clinical benefit as compared with single-chamber ventricular pacing, but the supporting evidence is ...

NEW ORLEANS, May 20, 2023 /PRNewswire/ -- Abbott today announced late-breaking results from the AVEIR™ dual-chamber (DR) i2i™ Investigational Device Exemption (IDE) study, a large-scale study to ...